Terms: = Gastric cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025
9 results:
1. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
[TBL] [Abstract] [Full Text] [Related]
2. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trial.
Chen J; Xiong J; Wang J; Zheng L; Gao Y; Guan Z
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e310-e316. PubMed ID: 29372626
[TBL] [Abstract] [Full Text] [Related]
3. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
Liu J; Deng N; Xu Q; Sun L; Tu H; Wang Z; Xing C; Yuan Y
Oncotarget; 2016 Jul; 7(30):48130-48142. PubMed ID: 27340861
[TBL] [Abstract] [Full Text] [Related]
4. Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks.
Liu J; Sun L; Xu Q; Tu H; He C; Xing C; Yuan Y
Oncotarget; 2016 Feb; 7(6):6972-83. PubMed ID: 26760766
[TBL] [Abstract] [Full Text] [Related]
5. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract] [Full Text] [Related]
6. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
[TBL] [Abstract] [Full Text] [Related]
7. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer.
Palli D; Polidoro S; D'Errico M; Saieva C; Guarrera S; Calcagnile AS; Sera F; Allione A; Gemma S; Zanna I; Filomena A; Testai E; Caini S; Moretti R; Gomez-Miguel MJ; Nesi G; Luzzi I; Ottini L; Masala G; Matullo G; Dogliotti E
Mutagenesis; 2010 Nov; 25(6):569-75. PubMed ID: 20817763
[TBL] [Abstract] [Full Text] [Related]
8. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.
Goekkurt E; Al-Batran SE; Hartmann JT; Mogck U; Schuch G; Kramer M; Jaeger E; Bokemeyer C; Ehninger G; Stoehlmacher J
J Clin Oncol; 2009 Jun; 27(17):2863-73. PubMed ID: 19332728
[TBL] [Abstract] [Full Text] [Related]
9. Polymorphisms of the DNA repair gene xpa and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China.
Dong Z; Guo W; Zhou R; Wan L; Li Y; Wang N; Kuang G; Wang S
J Clin Gastroenterol; 2008 Sep; 42(8):910-5. PubMed ID: 18645534
[TBL] [Abstract] [Full Text] [Related]
